The panel of eight men and four women also heard colourful accounts from several Theranos employees about the company’s lab taking dangerous shortcuts to conceal shortcomings with the analysers,and from patients who recounted receiving inaccurate test results that left them anxious about their health.
As was the case with the fate of Theranos itself,Holmes’s defence was tethered to her charisma and credibility. She made the risky decision,unusual in white-collar criminal cases,to testify in her own defence.
The move gave Holmes the final voice in the long trial - and served to dampen the testimony of dozens of government witnesses before her - but also forced her to make uncomfortable admissions during a gruelling cross-examination.